Lee JS - Search Results

1

Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial.

Jeong H, Kim KP, Jeong JH, Hwang DW, Lee JH, Kim KH, Moon DB, Lee MA, Park SJ, Chon HJ, Park JH, Lee JS, Ryoo BY, Yoo C. Jeong H, et al. Among authors: lee ma, lee js, lee jh. Hepatology. 2023 May 1;77(5):1540-1549. doi: 10.1097/HEP.0000000000000046. Epub 2023 Jan 3. Hepatology. 2023. PMID: 37070950 Clinical Trial.

2

Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer.

Kim D, Kim SY, Lee JS, Hong YS, Kim JE, Kim KP, Kim J, Jang SJ, Yoon YK, Kim TW. Kim D, et al. Among authors: lee js. BMC Gastroenterol. 2017 Nov 23;17(1):121. doi: 10.1186/s12876-017-0694-6. BMC Gastroenterol. 2017. PMID: 29169325 Free PMC article.

3

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers.

Park JH, Lee JS, Koo H, Kim JE, Ahn JH, Ryu MH, Park SR, Yoon SK, Lee JC, Hong YS, Kim SY, Kim KP, Yoo CH, Hong JY, Lee JL, Jung KH, Rhyoo BY, Kim TW. Park JH, et al. Among authors: lee js, lee jc, lee jl. J Cancer Educ. 2020 Jun;35(3):545-556. doi: 10.1007/s13187-019-01494-6. J Cancer Educ. 2020. PMID: 30820925

4

Pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization: a prospective randomized study for optimal apheresis.

Kang J, Hong JY, Yoon DH, Kim JE, Kim KP, Kim S, Lee KM, Park JS, Lee JS, Suh C. Kang J, et al. Among authors: lee js, lee km. Transfusion. 2019 May;59(5):1781-1788. doi: 10.1111/trf.15265. Epub 2019 Mar 29. Transfusion. 2019. PMID: 30924165 Clinical Trial.

5

Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial.

Hong YS, Kim SY, Lee JS, Nam BH, Kim KP, Kim JE, Park YS, Park JO, Baek JY, Kim TY, Lee KW, Ahn JB, Lim SB, Yu CS, Kim JC, Yun SH, Kim JH, Park JH, Park HC, Jung KH, Kim TW. Hong YS, et al. Among authors: lee js, lee kw. J Clin Oncol. 2019 Nov 20;37(33):3111-3123. doi: 10.1200/JCO.19.00016. Epub 2019 Oct 8. J Clin Oncol. 2019. PMID: 31593484 Clinical Trial.

6

Proton Pump Inhibitor Use and the Efficacy of Chemotherapy in Metastatic Colorectal Cancer: A Post Hoc Analysis of a Randomized Phase III Trial (AXEPT).

Kim SY, Lee JS, Kang J, Morita S, Park YS, Sakamoto J, Muro K, Xu RH, Kim TW. Kim SY, et al. Among authors: lee js. Oncologist. 2021 Jun;26(6):e954-e962. doi: 10.1002/onco.13735. Epub 2021 Mar 23. Oncologist. 2021. PMID: 33644953 Free PMC article. Clinical Trial.

7

Bevacizumab plus capecitabine as later-line treatment for patients with metastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines.

Bang YH, Kim JE, Lee JS, Kim SY, Kim KP, Kim TW, Hong YS. Bang YH, et al. Among authors: lee js. Sci Rep. 2021 Mar 29;11(1):7118. doi: 10.1038/s41598-021-86482-x. Sci Rep. 2021. PMID: 33782470 Free PMC article.

8

Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study.

Yoo C, Kim KP, Jeong JH, Kim I, Kang MJ, Cheon J, Kang BW, Ryu H, Lee JS, Kim KW, Abou-Alfa GK, Ryoo BY. Yoo C, et al. Among authors: lee js. Lancet Oncol. 2021 Nov;22(11):1560-1572. doi: 10.1016/S1470-2045(21)00486-1. Epub 2021 Oct 14. Lancet Oncol. 2021. PMID: 34656226 Clinical Trial.

9

Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer: The Phase 2b NIFTY Randomized Clinical Trial.

Hyung J, Kim I, Kim KP, Ryoo BY, Jeong JH, Kang MJ, Cheon J, Kang BW, Ryu H, Lee JS, Kim KW, Abou-Alfa GK, Yoo C. Hyung J, et al. Among authors: lee js. JAMA Oncol. 2023 May 1;9(5):692-699. doi: 10.1001/jamaoncol.2023.0016. JAMA Oncol. 2023. PMID: 36951834 Free PMC article. Clinical Trial.

10

Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice.

Bang YH, Hong YS, Lee JS, Lee KW, Han HS, Kim SY, Kim JW, Kim HK, Kim JW, Eun CK, Kim TW, Kim JE. Bang YH, et al. Among authors: lee js, lee kw. Clin Colorectal Cancer. 2021 Jun;20(2):101-112.e6. doi: 10.1016/j.clcc.2020.10.001. Epub 2020 Oct 28. Clin Colorectal Cancer. 2021. PMID: 33223477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,360 results

Search Page